Palo Alto Investors LP
Q4 2024 13F Holdings
- Locationpalo alto, CA
- Num holdings
43
- Value ($000)
$645,378
- Date Filed02/14/2025
- Form type13F-HR
- CIK0001306923
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
INSM INSMED INC | COM PAR $.01 | 457669307 | $110.70M | 17 % | 1,603,465 | ||
FOLD AMICUS THERAPEUTICS INC | COM | 03152W109 | $72.18M | 11 % | 7,662,479 | ||
BMRN BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | $70.15M | 11 % | 1,067,266 | ||
UTH UNITED THERAPEUTICS CORP | COM | 91307C102 | $54.94M | 9 % | 155,714 | ||
ACAD ACADIA PHARMACEUTICALS INC | COM | 004225108 | $50.44M | 8 % | 2,748,599 | ||
ALNY ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | $33.10M | 5 % | 140,681 | ||
BIIB BIOGEN INC | COM | 09062X103 | $29.08M | 5 % | 190,148 | ||
SRPT SAREPTA THERAPEUTICS INC | COM | 803607100 | $25.57M | 4 % | 210,258 | ||
NOVOCURE LTD | ORD SHS | G6674U108 | $24.26M | 4 % | 814,191 | ||
PROTHENA CORP PLC | SHS | G72800108 | $24.07M | 4 % | 1,737,964 |
Rows Per Page
1 - 10 of 4310
- 10
- 50
- 100